Integrating Epothilones into the Treatment of Patients with Metastatic Breast Cancer: Clinical Perspectives on Incorporating Recent Data in the Practice Setting

HER2-Positive Metastatic Breast Cancer Patients Receiving Pertuzumab in a Community Oncology Practice Setting: Treatment Patterns and Outcomes

Drugs - Real World Outcomes ◽

10.1007/s40801-016-0102-5 ◽

2017 ◽

Vol 4 (1) ◽

pp. 1-7 ◽

Cited By ~ 11

Author(s):

Nicholas J. Robert ◽

Hans-Peter Goertz ◽

Pooja Chopra ◽

Xiaolong Jiao ◽

Bongin Yoo ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Cancer Patients ◽

Metastatic Breast ◽

Treatment Patterns ◽

Practice Setting ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Community Oncology ◽

Oncology Practice

Download Full-text

Treatment of metastatic breast cancer with nab-paclitaxel in the community practice setting: a US oncology survey

The Journal of Community and Supportive Oncology ◽

10.12788/jcso.0132 ◽

2015 ◽

Vol 13 (5) ◽

pp. 173-180

Author(s):

Debra Patt ◽

Debra Rembert ◽

Deyanira Corzo

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Metastatic Breast ◽

Practice Setting ◽

Community Practice

Download Full-text

HSR21-051: Treatment Outcomes Among HR+/HER2- Advanced/Metastatic Breast Cancer Patients Receiving CDK 4 & 6 Inhibitors in a United States Clinical Practice Setting

Journal of the National Comprehensive Cancer Network ◽

10.6004/jnccn.2020.7739 ◽

2021 ◽

Vol 19 (3.5) ◽

pp. HSR21-051

Author(s):

Yu-Jing Huang ◽

Paula D. Ryan ◽

Gregory L. Price ◽

Gebra Cuyun Carter ◽

Kristin M. Sheffield ◽

...

Keyword(s):

Breast Cancer ◽

United States ◽

Metastatic Breast Cancer ◽

Clinical Practice ◽

Treatment Outcomes ◽

Cancer Patients ◽

Metastatic Breast ◽

Practice Setting ◽

Breast Cancer Patients ◽

Clinical Practice Setting

Download Full-text

Treatment ofpatients (pts) with HER2- metastatic breast cancer (MBC) with nab-paclitaxel (nab-P) in the clinical practice setting—Results of a US Oncology survey.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.e12008 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. e12008-e12008

Author(s):

Debra A. Patt ◽

Paula Richardson ◽

Debra Rembert ◽

Deyanira Corzo ◽

Clara Chen

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Clinical Practice ◽

Metastatic Breast ◽

Practice Setting ◽

Clinical Practice Setting

Download Full-text

A review of the newer aromatase inhibitors in the management of metastatic breast cancer

Journal of Clinical Pharmacy and Therapeutics ◽

10.1046/j.1365-2710.1998.00145.x ◽

1998 ◽

Vol 23 (2) ◽

pp. 81-90 ◽

Cited By ~ 7

Author(s):

Reddy

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Aromatase Inhibitors ◽

Metastatic Breast

Download Full-text

Influence of cumulative dose (CD) of trastuzumab administred wit taxanes vs pre-treatment CD of anthracyclin on left ventricular ejection fraction (LVEF) of metastatic breast cancer (MBC) patients

European Journal of Cancer ◽

10.1016/s0959-8049(02)80427-0 ◽

2002 ◽

Vol 38 (11) ◽

pp. S131

Author(s):

B Aunoble

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Left Ventricular Ejection Fraction ◽

Ejection Fraction ◽

Cumulative Dose ◽

Metastatic Breast ◽

Left Ventricular ◽

Left Ventricular Ejection ◽

Ventricular Ejection Fraction ◽

Pre Treatment

Download Full-text

Gemcitabine in metastatic breast cancer patients previously treated with anthracyclines and taxanes. Evaluation of response toxicity

European Journal of Cancer ◽

10.1016/s0959-8049(02)80224-6 ◽

2002 ◽

Vol 38 (11) ◽

pp. S74 ◽

Cited By ~ 2

Author(s):

G Lerzo

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Cancer Patients ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Previously Treated

Download Full-text

Safety of Herceptin monotherapy administered on a 3-weekly schedule: Preliminary data from a phase II study in women with HER2-positive metastatic breast cancer

European Journal of Cancer ◽

10.1016/s0959-8049(02)80299-4 ◽

2002 ◽

Vol 38 (11) ◽

pp. S95

Author(s):

J Baselga

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Preliminary Data ◽

Phase Ii Study ◽

Metastatic Breast ◽

Weekly Schedule ◽

Her2 Positive

Download Full-text

Epirubicin and vinorelbine versus single agent epirubicin as first line chemotherapy in metastatic breast cancer

European Journal of Cancer ◽

10.1016/s0959-8049(02)80197-6 ◽

2002 ◽

Vol 38 (11) ◽

pp. S66-S67

Author(s):

B Ejlertsen

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Single Agent ◽

Metastatic Breast ◽

First Line ◽

Line Chemotherapy

Download Full-text

Bevacizumab Approved for Metastatic Breast Cancer

Internal Medicine News ◽

10.1016/s1097-8690(08)70305-6 ◽

2008 ◽

Vol 41 (6) ◽

pp. 1-4

Author(s):

ELIZABETH MECHCATIE

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Metastatic Breast

Download Full-text